The purpose of this contract is to provide to tuberculosis researchers materials of consistently high quality prepared from M. tuberculosis and to provide a facility to evaluate candidate anti-tuberculosis vaccines in animal models. Mycobacteria are difficult organisms to grow requiring 3-4 weeks to produce a colony on solid culture medium. Because it is transmitted via aerosols, work with the organism will be done in BL3 laboratories. This research materials provided will include irradiated organisms, purified protein, lipid and carbohydrate antigens, culture filtrates, and nucleic acids. The animal models available for consideration include, but are not limited to, the mouse, guinea pig and rabbit. This service will enable and facilitate the participation of researchers (many of whom are without the required BLT facilities needed to culture quantities of M. tuberculosis or evaluate candidate vaccines and drugs under direct challenge conditions) in basic and clinical research projects that require these resources. It also allows the efficient use of facilities and materials as quantities of different materials may be purified from the same source material and standards for comparative evaluation of treatment or prophylactic efficacies developed. Access to research materials, such as purified antigens, prepared under defined protocols, allows greater interchange of information among interested researchers and objective comparison of data from different laboratories using the same materials.

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Colorado State University-Fort Collins
Schools of Arts and Sciences
Fort Collins
United States
Zip Code
Lucas, Megan C; Wolfe, Lisa M; Hazenfield, Rachel M et al. (2015) Fractionation and analysis of mycobacterial proteins. Methods Mol Biol 1285:47-75
Esin, S; Counoupas, C; Aulicino, A et al. (2013) Interaction of Mycobacterium tuberculosis cell wall components with the human natural killer cell receptors NKp44 and Toll-like receptor 2. Scand J Immunol 77:460-9
Cho, Yun Sang; Dobos, Karen M; Prenni, Jessica et al. (2012) Deciphering the proteome of the in vivo diagnostic reagent ""purified protein derivative"" from Mycobacterium tuberculosis. Proteomics 12:979-91
Driessen, Nicole N; Boshoff, Helena I M; Maaskant, Janneke J et al. (2012) Cyanovirin-N inhibits mannose-dependent Mycobacterium-C-type lectin interactions but does not protect against murine tuberculosis. J Immunol 189:3585-92
Laal, Suman (2012) How does Mycobacterium tuberculosis establish infection? J Infect Dis 206:1157-9
West, Nicholas P; Thomson, Scott A; Triccas, James A et al. (2011) Delivery of a multivalent scrambled antigen vaccine induces broad spectrum immunity and protection against tuberculosis. Vaccine 29:7759-65
Tullius, Michael V; Harmston, Christine A; Owens, Cedric P et al. (2011) Discovery and characterization of a unique mycobacterial heme acquisition system. Proc Natl Acad Sci U S A 108:5051-6
Cade, Christine E; Dlouhy, Adrienne C; Medzihradszky, Katalin F et al. (2010) Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activities. Protein Sci 19:458-74
Kumar, Parameet; Sen, Manas K; Chauhan, Devendra S et al. (2010) Assessment of the N-PCR assay in diagnosis of pleural tuberculosis: detection of M. tuberculosis in pleural fluid and sputum collected in tandem. PLoS One 5:e10220
McMath, L M; Habel, J E; Sankaran, B et al. (2010) Crystallization and preliminary X-ray crystallographic analysis of a Mycobacterium tuberculosis ferritin homolog, BfrB. Acta Crystallogr Sect F Struct Biol Cryst Commun 66:1657-61

Showing the most recent 10 out of 117 publications